Avidity Biosciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Avidity Biosciences's past years’ income statements indicate that its last revenue has increased compared to the previous period by 4% to $9,560,000. Profit margin reached -2220%. Total operating expenses were $245,158,000.
Profit Margin
| 2018 | 379K | -11.93M | -3148.81% |
|---|---|---|---|
| 2019 | 2.31M | -32.12M | -1385.12% |
| 2020 | 6.78M | -43.98M | -648.03% |
| 2021 | 9.32M | -117.37M | -1258.52% |
| 2022 | 9.22M | -169.07M | -1833.01% |
| 2023 | 9.56M | -212.22M | -2219.87% |
RNA Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 9.56M | 9.22M | 9.32M | 6.78M | 2.31M | 379K |
Cost of revenue | 2.10M | 1.38M | 639K | 37.60M | 14.53M | 0 |
Gross profit | 7.45M | 7.83M | 8.68M | -30.81M | -12.22M | 379K |
Operating exp. | ||||||
Research and development | 190.96M | 150.40M | 101.18M | 37.60M | 14.53M | 8.43M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 245.15M | 188.13M | 127.37M | 51.06M | 19.65M | 10.87M |
Operating income | -235.59M | -178.91M | -118.05M | -44.27M | -17.33M | -10.49M |
Other income (expenses), net | 23.37M | 4.91M | 42K | -78K | -7.40M | -718K |
Income before tax | -212.22M | -173.99M | -118.00M | -44.35M | -24.73M | -11.21M |
Income tax expense | 0 | -4.91M | -639K | -373K | 7.38M | 718K |
Net income | -212.22M | -169.07M | -117.37M | -43.98M | -32.12M | -11.93M |
Earnings per share | ||||||
Basic EPS | -2.91 | -3.24 | -2.83 | -2.03 | -0.86 | -0.58 |
Diluted EPS | -2.91 | -3.24 | -2.83 | -2.03 | -0.86 | -0.58 |
| Data source | Data source | Data source | Data source |